A Novel Gene, <i>erm</i> (41), Confers Inducible Macrolide Resistance to Clinical Isolates of <i>Mycobacterium abscessus</i> but Is Absent from <i>Mycobacterium chelonae</i>

Abstract excerpt

Mycobacterium abscessus infections tend to respond poorly to macrolide-based chemotherapy, even though the organisms appear to be susceptible to clarithromycin. Circumstantial evidence suggested that at least some M. abscessus isolates might be inducibly resistant to macrolides. Thus, the purpose of this study was to investigate the macrolide phenotype of M. abscessus clinical isolates. Inducible resistance to...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Infectious Diseases and Mycology
• Share to Mycobacterium research and diagnosis
• Share to Tuberculosis Research and Epidemiology